Overview
Medtech is a company operating at the intersection of medicine and technology. It supplies orthopedic implants and develops AI solutions for healthcare, including RefferAI for prescreening patients for clinical trials. Its offer also includes MTag devices and cooperation with global medical device manufacturers.
Financials
The financial statement for 2025 has not yet been filed with the Financial Document Repository (past deadline).
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Stock quotes
- Open
- PLN 0.34
- High
- PLN 0.34
- Low
- PLN 0.32
- Volume
- 295.59K
- Avg. vol.
- 504.48K
- Market cap
- PLN 25.37M
- P/E ratio
- —
- EPS
- -PLN 0.04
- Shares outstanding
- 75.5M
- 52-week
- PLN 0.32 – 0.38
- Dividend yield
- —
- Dividend
- —
- Ex dividend date
- —
- ISIN
- PLCCHT000014
- Exchange
- NewConnect
Quarterly results
| Period | Revenue | EBIT | Net profit |
|---|---|---|---|
| Q2 2026 | USD 110.75k | USD -95.62k | USD -97.51k |
| Q1 2026 | USD 99.41k | USD -94.27k | USD -94.27k |
| Q4 2025 | USD 49.97k | USD -404.57k | USD -406.83k |
| Q3 2025 | USD 4.77k | USD -133.10k | USD -157.96k |
Results for Q3 2026:Nov 16, 2026
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2024.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2015-09-09. Active
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
MSiG notices
| Publication date | Event | |
|---|---|---|
| Jun 6, 2017 | Shareholders' meeting convened |
Public aid
4 public aid cases recorded, with a total value of $9,933.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Dec 19, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | —— | Prezes Zakładu Ubezpieczeń Społecznych | |
| Dec 9, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | —— | Prezes Zakładu Ubezpieczeń Społecznych | |
| Dec 9, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | —— | Prezes Zakładu Ubezpieczeń Społecznych |
Tenders
1 tender recorded as contractor, with a total value of $88,716.
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Jan 19, 2026 | Zakup i dostawę endoprotez stawu biodrowego pierwotnych i rewizyjnych | $88,716$88,716 | Samodzielny Publiczny Zakład Opieki Zdrowotnej - Szpital Powiatowy w Piszu |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Authorized Representatives
Manner of representation
In the case of a one-person management board, the sole member of the management board is authorised to make declarations of will and sign on behalf of the company, whereas in the case of a multi-member management board, the President of the Management Board is authorised to do so independently, while the Vice-President is authorised to do so jointly with a second member of the management board or with a commercial proxy.
Supervisory board
Beneficial owners
| Person | Rights | |
|---|---|---|
Maciej Ryszard Nowak (40)  | Shareholder of a joint-stock company, 29.93% |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Vente Amicalesp. z o.o. | $1,850,028.63 | venteamicale.pl | ||
| Optimed Pro-Office Cirrosp. j. | $1,276,876.90 | cirro.pl | ||
| Meditechsp. z o.o. | $934,565.46 | meditech.pl | ||
| BL Medicasp. z o.o. + limited partnership | $886,794.58 | blmedica.pl | ||
| Model MedicalS.A. | $754,014.76 | modelmedical.pl | ||
| Kunctradesp. z o.o. | $720,968.35 | kunctrade.com | ||
| Dermomedica Internationalsp. z o.o. | $668,049.56 | dermomedica.pl | ||
| Orthoactivesp. z o.o. | $617,449.08 | orthoactive.pl | ||
| Softmedicasp. z o.o. | $481,553.31 | softmedica.com.pl | ||
| Tsafetysp. z o.o. | $366,427.34 | tsafety.pl |
Change history
| Date | Event | |
|---|---|---|
| 2026-05-26 | Address change (Rondo Ignacego Daszyńskiego 2b/Omnioffice, 00-843, Warszawa → Ul. Żelazna 59a/3.3, 00-848, Warszawa) | |
| 2025-08-07 | Address change (Ul. Długa 29, 00-238, Warszawa → Rondo Ignacego Daszyńskiego 2b/Omnioffice, 00-843, Warszawa) | |
| 2025-08-07 | Share capital change (1,510,000.00 PLN → 7,550,000.00 PLN) | |
| 2025-03-27 | Share capital change (1,000,000.00 PLN → 1,510,000.00 PLN) | |
| 2025-03-10 | Share capital change (14,000,000.00 PLN → 1,000,000.00 PLN) |
FAQ
Last updated: 2026-09-02